Cargando…
1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018
BACKGROUND: Several enteroviruses (EVs), including EV-A71 and EV-D68, have been associated with acute flaccid myelitis (AFM). Clinical features distinguishing AFM presentations associated with specific EV types are not well described. METHODS: EV-associated AFM was defined as any child presenting to...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809297/ http://dx.doi.org/10.1093/ofid/ofz359.119 |
_version_ | 1783461951753420800 |
---|---|
author | Messacar, Kevin Messacar, Kevin Spence-Davizon, Emily Osborne, Christina Press, Craig Schreiner, Teri Martin, Jan Messer, Ricka Maloney, John Burakoff, Alexis Barnes, Meghan Abzug, Mark Tyler, Ken Dominguez, Samuel |
author_facet | Messacar, Kevin Messacar, Kevin Spence-Davizon, Emily Osborne, Christina Press, Craig Schreiner, Teri Martin, Jan Messer, Ricka Maloney, John Burakoff, Alexis Barnes, Meghan Abzug, Mark Tyler, Ken Dominguez, Samuel |
author_sort | Messacar, Kevin |
collection | PubMed |
description | BACKGROUND: Several enteroviruses (EVs), including EV-A71 and EV-D68, have been associated with acute flaccid myelitis (AFM). Clinical features distinguishing AFM presentations associated with specific EV types are not well described. METHODS: EV-associated AFM was defined as any child presenting to Children’s Hospital Colorado in 2013–2018 who met the Council of State and Territorial Epidemiologists definition for confirmed AFM (flaccid limb weakness with longitudinal gray-matter-predominant spinal cord lesion on MRI) and had EV-A71 or EV-D68 identified in any biologic specimen (cerebrospinal fluid [CSF], nasopharyngeal [NP], oropharyngeal [OP], rectal) by VP1-specific RT-PCR and sequencing. Summative limb strength scores (SLSS) were calculated by adding Medical Research Council strength scores (1–5) for all limbs. RESULTS: Ten cases of EV-A71-associated AFM were identified, all from 2018; 8 cases of EV-D68-associated AFM were identified from 2013 (1), 2014 (4), 2016 (1), and 2018 (2) [Table 1]. Viral detection rates were higher in rectal and OP swabs in EV-A71 cases and NP specimens in EV-D68 cases. Virus was not detected in CSF of EV-D68 cases and in 1 EV-A71 case. EV-A71 cases were younger (median 19 vs. 100 months) and had neurologic onset earlier after prodromal symptom onset (median 1 vs. 5.5 days) than EV-D68 cases. Hand, foot, and/or mouth lesions distinguished EV-A71 cases, whereas respiratory symptoms were uniformly noted in EV-D68 cases. Associated neurologic findings more commonly associated with EV-A71 cases than EV-D68 cases included irritability, myoclonus, and ataxia. Weakness was more generalized with EV-A71 and more asymmetric with EV-D68, though patterns of brainstem and spinal cord involvement on MRI were similar. Compared with EV-D68, EV-A71 cases had milder weakness at onset and improved strength at 1- to 2-month follow-up (Figure 1), shorter length of stay (median 5.5 vs. 32 days) and a greater rate of full neurologic recovery (90% vs. 13%). CONCLUSION: EV-D68 and EV-A71 are both associated with AFM with similar MRI findings, but cases can be distinguished by associated prodromal symptoms, neurologic findings, and outcomes. Timely collection and testing of nonsterile site specimens, particularly NP for EV-D68 and OP and rectal for EV-A71, are key to case identification. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures. |
format | Online Article Text |
id | pubmed-6809297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68092972019-10-28 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018 Messacar, Kevin Messacar, Kevin Spence-Davizon, Emily Osborne, Christina Press, Craig Schreiner, Teri Martin, Jan Messer, Ricka Maloney, John Burakoff, Alexis Barnes, Meghan Abzug, Mark Tyler, Ken Dominguez, Samuel Open Forum Infect Dis Abstracts BACKGROUND: Several enteroviruses (EVs), including EV-A71 and EV-D68, have been associated with acute flaccid myelitis (AFM). Clinical features distinguishing AFM presentations associated with specific EV types are not well described. METHODS: EV-associated AFM was defined as any child presenting to Children’s Hospital Colorado in 2013–2018 who met the Council of State and Territorial Epidemiologists definition for confirmed AFM (flaccid limb weakness with longitudinal gray-matter-predominant spinal cord lesion on MRI) and had EV-A71 or EV-D68 identified in any biologic specimen (cerebrospinal fluid [CSF], nasopharyngeal [NP], oropharyngeal [OP], rectal) by VP1-specific RT-PCR and sequencing. Summative limb strength scores (SLSS) were calculated by adding Medical Research Council strength scores (1–5) for all limbs. RESULTS: Ten cases of EV-A71-associated AFM were identified, all from 2018; 8 cases of EV-D68-associated AFM were identified from 2013 (1), 2014 (4), 2016 (1), and 2018 (2) [Table 1]. Viral detection rates were higher in rectal and OP swabs in EV-A71 cases and NP specimens in EV-D68 cases. Virus was not detected in CSF of EV-D68 cases and in 1 EV-A71 case. EV-A71 cases were younger (median 19 vs. 100 months) and had neurologic onset earlier after prodromal symptom onset (median 1 vs. 5.5 days) than EV-D68 cases. Hand, foot, and/or mouth lesions distinguished EV-A71 cases, whereas respiratory symptoms were uniformly noted in EV-D68 cases. Associated neurologic findings more commonly associated with EV-A71 cases than EV-D68 cases included irritability, myoclonus, and ataxia. Weakness was more generalized with EV-A71 and more asymmetric with EV-D68, though patterns of brainstem and spinal cord involvement on MRI were similar. Compared with EV-D68, EV-A71 cases had milder weakness at onset and improved strength at 1- to 2-month follow-up (Figure 1), shorter length of stay (median 5.5 vs. 32 days) and a greater rate of full neurologic recovery (90% vs. 13%). CONCLUSION: EV-D68 and EV-A71 are both associated with AFM with similar MRI findings, but cases can be distinguished by associated prodromal symptoms, neurologic findings, and outcomes. Timely collection and testing of nonsterile site specimens, particularly NP for EV-D68 and OP and rectal for EV-A71, are key to case identification. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809297/ http://dx.doi.org/10.1093/ofid/ofz359.119 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Messacar, Kevin Messacar, Kevin Spence-Davizon, Emily Osborne, Christina Press, Craig Schreiner, Teri Martin, Jan Messer, Ricka Maloney, John Burakoff, Alexis Barnes, Meghan Abzug, Mark Tyler, Ken Dominguez, Samuel 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018 |
title | 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018 |
title_full | 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018 |
title_fullStr | 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018 |
title_full_unstemmed | 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018 |
title_short | 1889. Clinical Features Distinguishing Enterovirus A71 and Enterovirus D68-Associated Acute Flaccid Myelitis in Colorado, 2013–2018 |
title_sort | 1889. clinical features distinguishing enterovirus a71 and enterovirus d68-associated acute flaccid myelitis in colorado, 2013–2018 |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809297/ http://dx.doi.org/10.1093/ofid/ofz359.119 |
work_keys_str_mv | AT messacarkevin 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT messacarkevin 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT spencedavizonemily 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT osbornechristina 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT presscraig 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT schreinerteri 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT martinjan 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT messerricka 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT maloneyjohn 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT burakoffalexis 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT barnesmeghan 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT abzugmark 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT tylerken 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 AT dominguezsamuel 1889clinicalfeaturesdistinguishingenterovirusa71andenterovirusd68associatedacuteflaccidmyelitisincolorado20132018 |